AR240834A1 - Procedimiento para preparar derivados de 3beta-colestaniloxifosforilalquilamina - Google Patents

Procedimiento para preparar derivados de 3beta-colestaniloxifosforilalquilamina

Info

Publication number
AR240834A1
AR240834A1 AR297667A AR29766784A AR240834A1 AR 240834 A1 AR240834 A1 AR 240834A1 AR 297667 A AR297667 A AR 297667A AR 29766784 A AR29766784 A AR 29766784A AR 240834 A1 AR240834 A1 AR 240834A1
Authority
AR
Argentina
Prior art keywords
oxyphosphoryl
cholestanyl
3beta
preparing
procedure
Prior art date
Application number
AR297667A
Other languages
English (en)
Spanish (es)
Other versions
AR240834A2 (es
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of AR240834A1 publication Critical patent/AR240834A1/es
Publication of AR240834A2 publication Critical patent/AR240834A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AR297667A 1983-08-25 1984-08-22 Procedimiento para preparar derivados de 3beta-colestaniloxifosforilalquilamina AR240834A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH464483 1983-08-25

Publications (2)

Publication Number Publication Date
AR240834A1 true AR240834A1 (es) 1991-02-28
AR240834A2 AR240834A2 (es) 1991-02-28

Family

ID=4279973

Family Applications (1)

Application Number Title Priority Date Filing Date
AR297667A AR240834A1 (es) 1983-08-25 1984-08-22 Procedimiento para preparar derivados de 3beta-colestaniloxifosforilalquilamina

Country Status (21)

Country Link
US (1) US4680290A (da)
EP (1) EP0135762B1 (da)
JP (1) JPS6061595A (da)
KR (1) KR850001767A (da)
AR (1) AR240834A1 (da)
AT (1) ATE37883T1 (da)
AU (1) AU574706B2 (da)
CA (1) CA1252778A (da)
DE (1) DE3474552D1 (da)
DK (1) DK347584A (da)
ES (2) ES535391A0 (da)
FI (1) FI842830A7 (da)
GR (1) GR80196B (da)
HU (1) HU189929B (da)
IL (1) IL72725A (da)
MC (1) MC1618A1 (da)
NO (1) NO161679C (da)
NZ (1) NZ209275A (da)
PH (1) PH19849A (da)
PT (1) PT79130B (da)
ZA (1) ZA846430B (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1241947A (en) * 1985-05-31 1988-09-13 Pierre R. Proulx Conjugated polyene sterol derivatives as membrane probes
US4946834A (en) * 1988-12-23 1990-08-07 Smithkline Beecham Corporation Phosphonic acid substituted steroids as steroid 5α-reductase inhibitors
US5026882A (en) * 1988-12-23 1991-06-25 Smithkline Beecham Corporation Phosphinic acid substituted steroids as inhibitors of steroid 5α-reductase
CA2028759A1 (en) * 1989-11-22 1991-05-23 Jean-Marie Cassal Steroids
US5215972A (en) * 1989-11-22 1993-06-01 Hoffmann-La Roche Inc. Steroids
US5244887A (en) * 1992-02-14 1993-09-14 Straub Carl D Stanols to reduce cholesterol absorption from foods and methods of preparation and use thereof
WO1996016680A1 (en) * 1994-11-30 1996-06-06 Amur Research Corp. Phosphocholine drug derivatives
CA2223179A1 (en) * 1995-06-07 1996-12-19 Bob Dale Brown Phosphonic acid-based cationic lipids
JPH11507352A (ja) 1995-06-07 1999-06-29 ジンタ・インコーポレイテッド 新規カルバメート基本カチオン性脂質
JP2002514183A (ja) * 1996-09-17 2002-05-14 スーパージェン・インコーポレーテッド リン脂質薬剤誘導体
US5830432A (en) * 1997-03-31 1998-11-03 Amur Pharmacuticals, Inc. Phospholipid drug derivatives
ATE473759T1 (de) 1998-05-22 2010-07-15 Univ Leland Stanford Junior Bifunktionelle moleküle sowie darauf basierende therapien.
BR0107933A (pt) 2000-01-28 2004-01-06 Procter & Gamble Compostos de arginina saborosos e seus usos para saúde cardiovascular
US20030045473A1 (en) * 2002-07-19 2003-03-06 Sarama Robert Joseph Compositions, kits, and methods for cardiovascular health
CN102379684B (zh) 2005-04-28 2014-11-19 普罗透斯数字保健公司 药物信息系统
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
CA2671799A1 (en) * 2006-12-08 2008-06-12 Jado Technologies Gmbh Cholesterylamines for the treatment and prevention of infectious diseases
EP2398500B1 (en) 2009-02-20 2019-03-13 2-BBB Medicines B.V. Glutathione-based drug delivery system
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
US20250135007A1 (en) * 2021-12-20 2025-05-01 Ron Weiss Compositions comprising sterol-amino-phosphate compounds and methods of making and use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3248408A (en) * 1963-07-22 1966-04-26 Merck & Co Inc Purification of steroid phosphates

Also Published As

Publication number Publication date
DK347584D0 (da) 1984-07-13
NO843406L (no) 1985-02-26
ES8606879A1 (es) 1986-05-01
NZ209275A (en) 1987-06-30
NO161679B (no) 1989-06-05
JPS6061595A (ja) 1985-04-09
FI842830A0 (fi) 1984-07-13
EP0135762A2 (de) 1985-04-03
ES8602844A1 (es) 1985-12-01
AU3222584A (en) 1985-02-28
HUT34997A (en) 1985-05-28
DE3474552D1 (en) 1988-11-17
ES543646A0 (es) 1986-05-01
MC1618A1 (fr) 1985-07-18
PT79130B (en) 1986-11-14
PT79130A (en) 1984-09-01
KR850001767A (ko) 1985-04-01
AR240834A2 (es) 1991-02-28
HU189929B (en) 1986-08-28
PH19849A (en) 1986-07-22
ATE37883T1 (de) 1988-10-15
AU574706B2 (en) 1988-07-14
FI842830A7 (fi) 1985-02-26
ES535391A0 (es) 1985-12-01
GR80196B (en) 1985-01-02
IL72725A0 (en) 1984-11-30
DK347584A (da) 1985-02-26
EP0135762A3 (en) 1986-01-22
ZA846430B (en) 1985-04-24
US4680290A (en) 1987-07-14
NO161679C (no) 1989-09-13
EP0135762B1 (de) 1988-10-12
CA1252778A (en) 1989-04-18
IL72725A (en) 1988-07-31

Similar Documents

Publication Publication Date Title
ES535978A0 (es) Procedimiento para preparar derivados de tiazol
ES534787A0 (es) Procedimiento para preparar etinglicoles
ES526827A0 (es) Procedimiento para preparar derivados de n-fenilpirazol
ES536138A0 (es) Procedimiento para preparar derivados azolicos
ES537992A0 (es) Procedimiento para preparar 2-fenil-imidazoles
MX161088A (es) Procedimiento para preparar derivados de 1-metil-5-p-tolilpirrol-2-acetamida
ES533995A0 (es) Procedimiento para preparar imidasoles
ES539255A0 (es) Procedimiento para preparar derivados de isoquinoleina
MX158198A (es) Procedimiento para preparar derivados de amidinopiperidina
MX157033A (es) Procedimiento para preparar derivados de pirrolo quinoleina
ES524106A0 (es) Procedimiento para preparar derivados de n-fenilpirazol
MX157788A (es) Procedimiento para preparar derivados de oxima
ES534227A0 (es) Procedimiento para preparar piridinas
ES524830A0 (es) Procedimiento para preparar derivados de xantina
ES534377A0 (es) Procedimiento para preparar derivados de antraciclina
MX7403E (es) Procedimiento para preparar derivados de benzoil-ureas
ES527164A0 (es) Procedimiento para preparar derivados de 2-piperacinil-quinazolina
ES521847A0 (es) Procedimiento para preparar derivados de pleuromutilina
ES530037A0 (es) Procedimiento para preparar imidazolamidas
ES532485A0 (es) Procedimiento para producir derivados de tiatriazina
ES530626A0 (es) Procedimiento para preparar derivados de ciano-2-imidazopiridina
ES533024A0 (es) Procedimiento para preparar meta-o para-isopropenil-alfa-alfa-dimetilbencilamina
ES530573A0 (es) Procedimiento para preparar derivados de pirazol-1,5-a-piridina
ES528807A0 (es) Procedimiento para preparar compuestos de ftalocianina
ES532142A0 (es) Procedimiento para preparar derivados acilaminofenolicos